Prosecution Insights
Last updated: November 12, 2026

Chs Healthcare Ventures Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Chs Healthcare Ventures Inc. operates in the Medical Devices & Mechanical Engineering technology area with 1 pending office action currently active. This prosecution involves 1 distinct examiner and is conducted within a distinct art unit. This suggests an intellectual property strategy that relies on the assigned technical review process.

The busiest examiner for this portfolio is NORTH, ISABELLA SARAH HYO SO, who handles the busiest examiner pending office action. Because the active filings are limited to a distinct art unit, the technical standards applied remain consistent. Practitioners can focus their resources on the requirements of this examiner to resolve the pending matter efficiently.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NORTH, ISABELLA SARAH HYO SO 1 63.6% +15.0%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17579206 Method and Manufacture of a dual lumen fiber optic medical infusion line NORTH, ISABELLA SARAH HYO SO —

Top Art Units

Art UnitApps
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17579206 Method and Manufacture of a dual lumen fiber optic medical infusion line NORTH, ISABELLA SARAH HYO SO 3783 §103 Final Rejection — Pending Jan 19, 2022

Managing Chs Healthcare Ventures Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Chs Healthcare Ventures Inc. have?

Chs Healthcare Ventures Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Chs Healthcare Ventures Inc. applications?

Isabella Sarah Hyo So North has the most, with 1 of Chs Healthcare Ventures Inc.'s pending office actions.

What technology area are Chs Healthcare Ventures Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month